Skip to main content
. 2015 May;8(3):131–136. doi: 10.1177/1756285615578406

Table 1.

Pharmacokinetic parameters of USL255 200 mg once daily versus immediate-release topiramate 100 mg twice daily at steady state.

USL255 Immediate-release topiramate
Area under curve (mg h/L) 158 (32) 153 (33)
Peak plasma concentration (mg/L) 7.9 (1.5) 8.4 (1.7)
Trough plasma concentration (mg/L) 5.3 (1.2) 5.0 (1.2)